Inhibition of phospholipase D2 augments histone deacetylase inhibitor-induced cell death in breast cancer cells

被引：0
|
作者：
Won Chan Hwang
Dong Woo Kang
Youra Kang
Younghoon Jang
Jung-Ae Kim
Do Sik Min
机构：
[1] Pusan National University,Department of Molecular Biology, College of Natural Science
[2] Yonsei University,College of Pharmacy
[3] Yeungnam University,College of Pharmacy
[4] Changwon National University,Department of Biology and Chemistry
来源：
Biological Research | / 53卷
关键词：
Phospholipase D2; Histone deacetylase inhibitor; Apoptosis; Angiogenesis; Chemoresistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Inhibition of phospholipase D2 induces autophagy in colorectal cancer cells
    Won Chan Hwang
    Mi Kyoung Kim
    Ju Hyun Song
    Kang-Yell Choi
    Do Sik Min
    Experimental & Molecular Medicine, 2014, 46 : e124 - e124
  • [22] Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells
    Li, Xiaohua
    Chen, Di
    Yin, Shuping
    Meng, Yonghong
    Yang, Huanjie
    Landis-Piwowar, Kristin R.
    Li, Yiwei
    Sarkar, Fazlul H.
    Reddy, G. Prem Veer
    Dou, Q. Ping
    Sheng, Shijie
    JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 212 (02) : 298 - 306
  • [23] Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells
    Phillip, Cornel J.
    Giardina, Christopher K.
    Bilir, Birdal
    Cutler, David J.
    Lai, Yu-Heng
    Kucuk, Omer
    Moreno, Carlos S.
    BMC CANCER, 2012, 12
  • [24] Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells
    Cornel J Phillip
    Christopher K Giardina
    Birdal Bilir
    David J Cutler
    Yu-Heng Lai
    Omer Kucuk
    Carlos S Moreno
    BMC Cancer, 12
  • [25] Adenosine A2A receptor agonist protects PC12 cells from histone deacetylase inhibitor-induced cell death by activating ERK and Akt pathways
    Ouzumi, Satoshi
    Inden, Masatoshi
    Murata, Risa
    Fujioka, Hiromi
    Fujita, Norihisa
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 258P - 258P
  • [26] Histone deacetylase inhibition and estrogen signalling in human breast cancer cells
    Margueron, R
    Duong, V
    Castet, A
    Cavaillès, V
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 1239 - 1246
  • [27] BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis
    Ulrike Heinicke
    Tinka Haydn
    Sarah Kehr
    Meike Vogler
    Simone Fulda
    Oncogene, 2018, 37 : 5325 - 5339
  • [28] BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis
    Heinicke, Ulrike
    Haydn, Tinka
    Kehr, Sarah
    Vogler, Meike
    Fulda, Simone
    ONCOGENE, 2018, 37 (39) : 5325 - 5339
  • [29] Bioinspired black phosphorus delivers histone deacetylase inhibitor-induced synergistic therapy for lung cancer
    Li, Huan
    Guan, Xiaoling
    Li, Songpei
    Deng, Xiaohua
    Lin, Yinshan
    Wu, Dan
    Wu, Yuanyuan
    Zhou, Dazhi
    Tao, Yiwen
    Fan, Mingde
    Zhang, Lingmin
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2025, 680 : 298 - 310
  • [30] Lysophosphatidic acid protects cancer cells from histone deacetylase (HDAC) inhibitor-induced apoptosis through activation of HDAC
    Ishdorj, Ganchimeg
    Graham, Bonnie A.
    Hu, Xiaojie
    Chen, Jing
    Johnston, James B.
    Fang, Xianjun
    Gibson, Spencer B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (24) : 16818 - 16829
12345